Literature DB >> 21905198

Early endocrine and molecular changes in metabolic syndrome models.

Carlos Larqué1, Myrian Velasco, Victor Navarro-Tableros, Mariana Duhne, Jonathan Aguirre, Gabriela Gutiérrez-Reyes, Jaime Moreno, Guillermo Robles-Diaz, Enrique Hong, Marcia Hiriart.   

Abstract

The twenty-first century arrived in the middle of a global epidemic of metabolic syndrome (MS) and type 2 diabetes mellitus (DM2). It is generally accepted that an excess of nutrients linked to a low physical activity triggers the problem. However, the molecular features that interact to develop the MS are not clear. In an effort to understand and control them, they have been extensively studied, but this goal has not been achieved yet. Nonhuman animal models have been used to explore diet and genetic factors in which experimental conditions are controlled. For example, only one factor in the diet, such as fats or carbohydrates can be modified to better understand a single change that would be impossible in humans. Most of the studies have been done in rodents. However, it is difficult to directly compare them, because experiments are different in more than one variable; genetic strains, amount, and the type of fat used in the diet and sex. Thus, the only possible criteria of comparison are the relevance of the observed changes. We review different animal models and add some original observations on short-term changes in metabolism and beta cells in our own model of adult Wistar rats that are not especially prone to get fat or develop DM2, treated with 20% sucrose in drinking water. One early change observed in pancreatic beta cells is the increase in GLUT2 expression that is located to the membrane of the cells. This change could partially explain the presence of insulin hypersecretion and hyperinsulinemia in these rats. Understanding early changes that lead to MS and in time to pancreatic islet exhaustion is an important biomedical problem that may contribute to learn how to prevent or even reverse MS, before developing DM2.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21905198     DOI: 10.1002/iub.544

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  16 in total

Review 1.  β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes.

Authors:  Laura I Hudish; Jane Eb Reusch; Lori Sussel
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

2.  The functional activity of adenylyl cyclase signaling system in the brain, myocardium, and testes of rats with 8- and 18-month neonatal diabetes.

Authors:  K V Derkach; A O Shpakov; I V Moyseuk; O V Chistyakova
Journal:  Dokl Biochem Biophys       Date:  2013-03-13       Impact factor: 0.788

3.  Liraglutide Compromises Pancreatic β Cell Function in a Humanized Mouse Model.

Authors:  Midhat H Abdulreda; Rayner Rodriguez-Diaz; Alejandro Caicedo; Per-Olof Berggren
Journal:  Cell Metab       Date:  2016-02-11       Impact factor: 27.287

Review 4.  Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms.

Authors:  Pablo Pánico; Myrian Velasco; Ana María Salazar; Arturo Picones; Rosa Isela Ortiz-Huidobro; Gabriela Guerrero-Palomo; Manuel Eduardo Salgado-Bernabé; Patricia Ostrosky-Wegman; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

5.  Metabolic syndrome induces changes in KATP-channels and calcium currents in pancreatic β-cells.

Authors:  Myrian Velasco; Carlos Larqué; Gabriela Gutiérrez-Reyes; Reynaldo Arredondo; Carmen Sanchez-Soto; Marcia Hiriart
Journal:  Islets       Date:  2012-07-01       Impact factor: 2.694

6.  Metabolic syndrome remodels electrical activity of the sinoatrial node and produces arrhythmias in rats.

Authors:  Alondra Albarado-Ibañez; José Everardo Avelino-Cruz; Myrian Velasco; Julián Torres-Jácome; Marcia Hiriart
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

7.  Ingested capsaicinoids can prevent low-fat-high-carbohydrate diet and high-fat diet-induced obesity by regulating the NADPH oxidase and Nrf2 pathways.

Authors:  Kazim Sahin; Cemal Orhan; Mehmet Tuzcu; Nurhan Sahin; Oguzhan Ozdemir; Vijaya Juturu
Journal:  J Inflamm Res       Date:  2017-11-13

8.  Increased anxiety-like behavior is associated with the metabolic syndrome in non-stressed rats.

Authors:  Daniela Rebolledo-Solleiro; Gabriel Roldán-Roldán; Daniel Díaz; Myrian Velasco; Carlos Larqué; Guadalupe Rico-Rosillo; Gloria Bertha Vega-Robledo; Elena Zambrano; Marcia Hiriart; Miguel Pérez de la Mora
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

9.  Hyperinsulinemia is Associated with Increased Soluble Insulin Receptors Release from Hepatocytes.

Authors:  Marcia Hiriart; Carmen Sanchez-Soto; Carlos Manlio Diaz-Garcia; Diana T Castanares; Morena Avitia; Myrian Velasco; Jaime Mas-Oliva; Marina Macias-Silva; Clicerio González-Villalpando; Blanca Delgado-Coello; Marcela Sosa-Garrocho; Román Vidaltamayo; Deyanira Fuentes-Silva
Journal:  Front Endocrinol (Lausanne)       Date:  2014-06-19       Impact factor: 5.555

Review 10.  Molecular Insulin Actions Are Sexually Dimorphic in Lipid Metabolism.

Authors:  Rosa Isela Ortiz-Huidobro; Myrian Velasco; Carlos Larqué; Rene Escalona; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.